Travere Therapeutics, Inc. (TVTX) stock analysis

In our weekly check, Travere Therapeutics, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 10.

About Travere Therapeutics, Inc.

Travere Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TVTX.

What our checks show for TVTX

Red flags

Warning signs

Strengths

Similar companies

IONS · EWTX · COGT · ADPT · DNTH · SRRK

Questions

What grade does Travere Therapeutics, Inc. (TVTX) have?

In our weekly check, Travere Therapeutics, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of TVTX stock?

This week's biggest flags for Travere Therapeutics, Inc.: High debt, Weak interest cover, Weak EPS growth. In total 11 of 22 checks show a warning or a red flag.

What does Travere Therapeutics, Inc. do?

Travere Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TVTX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis